RF Energy Alliance Momentum and Growth Highlighted at EuMW 2016
The RF Energy Alliance (RFEA) announces an updated specifications roadmap to guide further RF energy application development. The Alliance also welcomes its newest members: E-REON, Midea, NXP® Semiconductors, AFT microwave GmbH, and Kennedy Labs.
The updated specifications roadmap continues to set the course for achieving the RFEA’s vision and development goals:
- The Systems Integration Guidelines
- RF PA Roadmap: Industrial Applications (915MHz)
- Solid-State RF Value Assessment Standard
- Revision 2 - RF PA Roadmap: Residential Appliances (2.45 GHz, consumer and professional)
The RFEA membership has tripled since its formation in the fall of 2014. The most recent companies and organizations to join the Alliance are:
- E-REON B.V.: With more than 160 years of accumulated experience in the design and development of RF and Microwave hardware, E-REON B.V. delivers turn-key solutions and services in Power RF and MW applications (heating, ignition, and lighting), Telecom Industry, Broadcast, and Aerospace and Defense.
- Midea: Produces a wide range of lighting, water appliances, floor care, small kitchen appliances, laundry, large cooking appliances, and refrigeration, in addition to well-known specialty in home- and commercial-grade heating, ventilation and air conditioning (HVAC) products.
- NXP Semiconductors: Enables secure connections and infrastructure for a smarter world, advancing solutions that make lives easier, better and safer. NXP’s portfolio of RF solutions is vast and spans wireless infrastructure, broadcast, industrial scientific and medical, land mobile radio and cooking applications.
- AFT microwave GmbH: From microwave materials, to components and up to complete system solutions, AFT has many years of experience in providing well-proven successful advice and products for microwave technology applications.
- Kennedy Labs: Kennedy Labs creates ALD and CVD graphene to enhance and miniaturize heat spreading materials used in high-power amplifiers for microelectronics, including RF Energy applications.
The RFEA is exhibiting at the European Microwave Week 2016, October 4-6, 2016 in London, UK and will be hosted by member company Ampleon (Stand 145) throughout the show. The RFEA executive director Dr. Klaus Werner will also be on hand to answer attendee questions about the Alliance at the following member stands during the exhibit hours (BST) listed below:
Tuesday, 4 October
- 15:00 MACOM – Stand 207
- 16:30 NXP – Stand 96
Wednesday, 5 October
- 11:00 Huber+Suhner – Stand 102
- 13:00 Rogers Corp. – Stand 204
About the RF Energy Alliance
The RF Energy Alliance is a non-profit technical association comprised of companies dedicated to realizing solid-state RF energy’s true potential as a clean, highly efficient and controllable heat and power source. Members share the vision of building a fast-growing, innovative marketplace around the sustainable technology, thereby contributing to quality of life across many application areas. The Alliance was founded in September 2014 by Ampleon, E.G.O. Elektro-Gerätebau GmbH, Huber+Suhner, ITW, Rogers Corporation and Whirlpool R&D (an affiliate company of Whirlpool Corporation).
Joe Balich, +1-503-619-4113
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease18.7.2018 21:45 | Pressemelding
VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July 2017 to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The article reports results that showed significantly fewer sickle cell crises in those receiving Endari compared to placebo by 25 percent; p=0.005 (median 3 vs. median 4) and significantly fewer hospitalizations by 33 percent; p=0.005 (median 2 vs. median 3). Additional findings showed lower cumulative days in hospital of 41 percent; p=0.02 (median 6.5 days vs. median 11 days) and a lower incidence of acute chest syndrome (ACS) by more than 60 percent; p=0.003 (13 of 152 patients [8.6%] had at least 1 ACS compared with 18 of 78 in the placebo group [23.1%]). The most common adverse reactions, occurring in great
Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 19:41 | Pressemelding
Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the
ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21 | Pressemelding
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li
Xilam: H1 2018 Revenue: +50%18.7.2018 16:00 | Pressemelding
Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t
Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38 | Pressemelding
The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign
Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05 | Pressemelding
Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d